SRR1316921
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- PANCREAS_BETA_CELLS+0.336
- KRAS_SIGNALING_DN+0.274
- HEDGEHOG_SIGNALING+0.157
- OXIDATIVE_PHOSPHORYLATION+0.138
- SPERMATOGENESIS+0.099
- MYOGENESIS+0.088
- REACTIVE_OXYGEN_SPECIES_PATHWAY+0.040
- ALLOGRAFT_REJECTION+0.024
- PEROXISOME+0.011
- APICAL_SURFACE-0.023
Top 10 suppressed
- TGF_BETA_SIGNALING-0.500
- G2M_CHECKPOINT-0.484
- MITOTIC_SPINDLE-0.482
- E2F_TARGETS-0.445
- ANGIOGENESIS-0.422
- MYC_TARGETS_V1-0.378
- ANDROGEN_RESPONSE-0.366
- TNFA_SIGNALING_VIA_NFKB-0.347
- PROTEIN_SECRETION-0.342
- UV_RESPONSE_DN-0.326
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1319837 | GTEX | — | 0.958 |
| 2 | SRR1311182 | GTEX | — | 0.956 |
| 3 | SRR1319970 | GTEX | — | 0.934 |
| 4 | 52425995-0bd7-4149-bc2a-26522ebd143d | — | — | 0.917 |
| 5 | SRR1414897 | GTEX | — | 0.910 |
| 6 | MDT-AP-2026 | Med | Medulloblastoma | 0.902 |
| 7 | MNG1089 | — | — | 0.899 |
| 8 | d2c9b21d-0f64-4182-9d5d-82b80a158a1f | — | — | 0.899 |
| 9 | 4e64826b-fffb-4430-bc34-ea6086e89a0a | — | — | 0.898 |
| 10 | SJEPD007_D.RNA-Seq | EPN | Posterior Fossa EPN | 0.894 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 9 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| PANCREAS_BETA_CELLS | 0.336 | Cobimetinib | — uncovered |
| KRAS_SIGNALING_DN | 0.274 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.157 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.138 | Remibrutinib | — uncovered |
| SPERMATOGENESIS | 0.099 | Inavolisib | — uncovered |
| MYOGENESIS | 0.088 | Inavolisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.040 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.024 | Idelalisib | — uncovered |
| PEROXISOME | 0.011 | Idelalisib | — uncovered |